Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

Viewing Page 2 of 8 | Showing Results 6 - 10 of 36

A Multicenter, Open-Label, Randomized Study of NovoTTF-200A Alone and Combined with Temozolomide in Patients with Low-Grade Gliomas

Key Inclusion Criteria:-Histologically confirmed, measureable low-grade glioma including grade 2 astrocytoma, oligdendroglioma, or...

Ricky Chen, M.D.
  • Providence St. Vincent Medical Center

A Phase 3, Randomized, Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic strocytoma That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy STELLAR Study

The purpose of this study is to compare the efficacy and safety of eflornithine in combination with lomustine, compared to lomustine taken alone,...

Ricky Chen, M.D.

METIS: Pivotal, open-label, randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC)

The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NSCLC...

Ricky Chen, M.D.
  • Providence St. Vincent Medical Center

EffectiveNess and SAfety of Small ANeurysm COiling Trial

To compare the safety and efficacy of treating small aneurysms with coils specially designed for small aneurysms to historically reported rates of...

Stephen Monteith, M.D.
  • Swedish Medical Center

Measurement of Relaxin in the Serum and Cerebrospinal Fluid of Subjects With and Without the Relapsing Form of Multiple Sclerosis

This study will evaluate relaxin (RLX) levels in patients with multiple sclerosis. Key Eligibilities: -Females 18 to 45 years of age.-Patients with...

Stanley Cohan, M.D., Ph.D.
  • Providence St. Vincent Medical Center
Viewing Page 2 of 8 | Showing Results 6 - 10 of 36